The U.S. Real World Evidence Solutions Market is projected to reach $2.01 billion by 2028, at a CAGR of 13.1% from 2021 to 2028. The growth of this market is driven by the rising prevalence of chronic diseases, rapidly growing big data in healthcare, the shift from volume to value-based care, and the rising focus on personalized healthcare.